Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06435897 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T Cells

StatusNot Yet Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 5 months later Jul 15, 2027 → Dec 31, 2028
See other at-risk trials from Shenzhen Geno-Immune Medical Institute

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jul 15, 2027 to Dec 31, 2028v4 Show 5 more changesShow less
    • Start date: May 15, 2024 to Jun 30, 2027
    • Trial status changed: Recruiting → Not Yet Recruiting
    • Study completion pushed from Dec 31, 2027 to Dec 31, 2029
    • Study description expanded, about 66 words
    • Site details revised
  2. Site contact updatedv3
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to assess the feasibility, safety and efficacy of mesenchymal stem cells (MSCs) in combination with CAR-T cells in treating autoimmune disease. Another goal of the study is to learn more about the safety and function of the MSCs combined with CAR-T cells and their long term effects in autoimmune disease patients.
Trial Details
NCT Number NCT06435897
Lead Sponsor Shenzhen Geno-Immune Medical Institute
Conditions
(from sponsor)		 Autoimmune Diseases
Related terms Autoimmune Diseases
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov